Nicotinamide could halve Australia’s healthcare costs for skin cancers
A new health economics analysis paper has been presented to Australian lawmakers at Parliament House to show how nicotinamide could double the cost benefits of its use.
News, Analysis & Insights on Nutrition, Supplements, and Health
A new health economics analysis paper has been presented to Australian lawmakers at Parliament House to show how nicotinamide could double the cost benefits of its use.
'no evidence of benefit in this population'
There is no evidence that the probiotic strain Bifidobacterium breve can reduce the risk of necrotising enterocolitis (NEC), late-onset sepsis and death in preterm infants, a study of 1315 infants has found.
Danish firm Asiros is using its extraction processes to bring the Nordic redcurrant (Ribes Rubrum) to market at high doses.
The European Commission has cleared the acquisition of French ingredient supplier Solina by private investment company Ardian.